Trials / Completed
CompletedNCT03173456
Comparing Five Oral Analgesics for Treatment of Acute Pain in the Emergency Department (ED)
Comparing the Efficacy of Five Oral Analgesics for Treatment of Acute Musculoskeletal Extremity Pain in the Emergency Department
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- 21 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
This study compares the efficacy of five oral analgesics: 5 mg oxycodone + 325 mg acetaminophen, 5 mg hydrocodone + 300 mg acetaminophen, 30 mg codeine + 300 mg acetaminophen, 400 mg ibuprofen + 1000 mg acetaminophen, and 800 mg ibuprofen + 1000 mg acetaminophen for the treatment of patients with acute musculoskeletal pain who present to the Emergency Department (ED).
Detailed description
The optimal treatment of musculoskeletal extremity pain in the ED not known. The study is a randomized controlled trial designed to compare the efficacy of five oral analgesics: 5 mg oxycodone + 325 mg acetaminophen, 5 mg hydrocodone + 300 mg acetaminophen, 30 mg codeine + 300 mg acetaminophen, 400 mg ibuprofen + 1000 mg acetaminophen, and 800 mg ibuprofen + 1000 mg acetaminophen for the treatment of patients with acute musculoskeletal pain. The primary outcome is the between treatment group difference in change in patients' rating of pain intensity one hour after ingestion of the study medication. Secondary outcomes include: 1) the between treatment group difference in change in patients' rating of pain intensity two hours after ingestion of the study medication; 2) difference in proportion of patients who receive rescue medication; 3) difference in proportion of patients who would choose to take the study medication again if they returned to the ED with similar pain; 4) difference in proportion of patients who experience side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oxycodone/APAP | Oxycodone/acetaminophen 5 mg-325 mg oral tablet |
| DRUG | hydrocodone/APAP | Hydrocodone/Acetaminophen 5 Mg-300 Mg oral tablet |
| DRUG | codeine/APAP | Codeine/acetaminophen 30 mg-300mg oral tablet |
| DRUG | 400 ibuprofen/APAP | ibuprofen/acetaminophen 400 mg-1000mg oral tablet |
| DRUG | 800 ibuprofen/APAP | ibuprofen/acetaminophen 800 mg-1000 mg oral tablet |
Timeline
- Start date
- 2017-11-28
- Primary completion
- 2019-11-14
- Completion
- 2019-11-14
- First posted
- 2017-06-01
- Last updated
- 2022-02-01
- Results posted
- 2022-02-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03173456. Inclusion in this directory is not an endorsement.